SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Utilisation of prophylactic mastectomy in 10 European centers

Evans, DG; Anderson, E; Lalloo, F; Vasen, H; Beckmann, M; Eccles, D; Hodgson, S; Møller, P; Chang-Claude, J; Morrison, P; et al. Evans, DG; Anderson, E; Lalloo, F; Vasen, H; Beckmann, M; Eccles, D; Hodgson, S; Møller, P; Chang-Claude, J; Morrison, P; Stoppa-Lyonnet, D; Steel, M; Haites, N (1999) Utilisation of prophylactic mastectomy in 10 European centers. DISEASE MARKERS, 15 (1-3). 148 - 151 (4). ISSN 0278-0240
SGUL Authors: Hodgson, Shirley Victoria

[img]
Preview
["document_typename_application/pdf; charset=binary" not defined] Published Version
Download (27kB) | Preview

Abstract

ABSTRACT: Increasingly women at high risk of breast cancer are opting for prophylactic surgery to reduce their risks. Data from 10 European centres that offer a risk counselling and screening service to women at risk show different approaches to the option of preventive surgery, although most centres adhere to a protocol including at least two risk counselling sessions and a psychological assessment. Thus far the combined centres have data on 174 women who have undergone prophylactic mastectomy with in excess of 400 women years of follow up. Operations were carried out on women with lifetime risks of 25–80%, with an average annual expected incidence rate of 1% per women. No breast cancers have occurred in this cohort. Long term follow up on an extended group of women will be necessary to truly address the risk of subsequent breast cancer and the psychological sequelae.

Item Type: Article
Additional Information: PubMed ID: 10595270
Keywords: Adult, BRCA2 Protein, Breast Neoplasms, Cohort Studies, Europe, Family Health, Female, Follow-Up Studies, Genes, BRCA1, Genetic Counseling, Genetic Testing, Humans, Mammaplasty, Mastectomy, Middle Aged, Neoplasm Proteins, Neoplastic Syndromes, Hereditary, Oncogenes, Patient Education as Topic, Risk, Transcription Factors, Science & Technology, Life Sciences & Biomedicine, Biotechnology & Applied Microbiology, Genetics & Heredity, Medicine, Research & Experimental, Pathology, Research & Experimental Medicine, BIOTECHNOLOGY & APPLIED MICROBIOLOGY, GENETICS & HEREDITY, MEDICINE, RESEARCH & EXPERIMENTAL, PATHOLOGY, BREAST-CANCER, BRCA1, CARRIERS, GENE
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) > Cell Sciences (INCCCS)
Journal or Publication Title: DISEASE MARKERS
ISSN: 0278-0240
Related URLs:
Dates:
DateEvent
1 October 1999Published
Web of Science ID: WOS:000083988300050
Download EPMC Full text (PDF)
Download EPMC Full text (HTML)
URI: https://openaccess.sgul.ac.uk/id/eprint/104389

Actions (login required)

Edit Item Edit Item